Aberrant T-cell antigen expression in B lymphoblastic leukaemia

British Journal of Haematology

Volumn 155, Issue 4, 2011, Pages 449-456

  Hussein, Shafinaz ^a   Gill, Kamraan Z ^a   Sireci, Anthony N ^a   Colovai, Adriana I ^a   Small, Tania ^a   Emmons, Foxwell N ^a   Murty, Vundavalli V ^a   Bhagat, Govind ^a   Alobeid, Bachir ^a  

^a Department of Medicine   (United States)

Author keywords

Acute lymphoblastic leukaemia; B lymphoblastic leukaemia; NK cell antigen; T cell antigen

Indexed keywords

CD2 ANTIGEN; CD4 ANTIGEN; CD5 ANTIGEN; CD56 ANTIGEN; CD7 ANTIGEN;

ADOLESCENT; ADULT; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOBLASTIC LEUKEMIA; BONE MARROW BIOPSY; CANCER RISK; CHILD; CONTROLLED STUDY; CYTOGENETICS; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; LYMPHATIC LEUKEMIA; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SCHOOL CHILD;

ACUTE DISEASE; ADOLESCENT; ADULT; ANTIGENS, CD; ANTIGENS, VIRAL, TUMOR; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOPHENOTYPING; INFANT; LEUKEMIA, B-CELL; MALE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; T-LYMPHOCYTES; YOUNG ADULT;

EID: 80054978337     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2011.08870.x     Document Type: Article

References (32)

1. Ahmed, D., Ahmed, T.A., Ahmed, S., Tipu, H.N. & Wiqar, M.A. (2008) CD5-positive acute lymphoblastic leukemia. Journal of College of Physicians and Surgeons Pakistan, 18, 310-311.
2. Albersten, B.K. (2000) Pharmacokinetics of Asparaginase and Antibody Formation in Interfant-06. In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). Available from NLM Identifier: NCT01025804.
3. Basso, G., Putti, M.C., Cantú-Rajnoldi, A., Saitta, M., Santostasi, T., Santoro, N., Lippi, A., Comelli, A., Felici, L., Favre, C., Mancuso, G.R., Guglielmi, C., Paolucci, P., Biondi, A., Rondelli, R. & Pession, A. (1992) The immunophenotype in infant acute lymphoblastic leukaemia: correlation with clinical outcome. An Italian multicentre study (AIEOP). British Journal of Haematology, 81, 184-191.
4. Bene, M.C., Castoldi, G., Knapp, W., Ludwig, W.D., Matutes, E., Orfao, A. & van't Veer, M.B. (1995) Proposals for the immunological classification of acute leukemias. European Group for the Immunological Characterization of Leukemias (EGIL). Leukemia, 9, 1783-1786.
5. Bradstock, K.F., Kirk, J., Grimsley, P.G., Kabral, A. & Hughes, W.G. (1989) Unusual immunophenotypes in acute leukaemias: incidence and clinical correlations. British Journal of Haematology, 72, 512-518.
6. Cairo, M. (2000) Less intensive therapy for children with non-Hodgkin's lymphoma. In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). Available from NLM Identifier: NCT00002757.
7. Cantu-Rajnoldi, A., Putti, M.C., Schiro, R., Biondi, A., Cattoretti, G., Valeggio, C., Castagni, M. & Basso, G. (1992) Biological and clinical features of B-precursor childhood acute lymphoblastic leukemia showing CD2 and/or E-rosette co-expression. Haematologica, 77, 384-391.
8. Dreyer, Z.E. (2000) Induction Intensification in Treating Infants With Newly Diagnosed Acute Lymphoblastic Leukemia. In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). Available from NLM Identifier: NCT00002756.
9. Dunphy, C.H. & Chu, J.Y. (1996) Aberrant CD2 expression in precursor-B acute lymphoblastic leukemia of childhood. American Journal of Hematology, 52, 224-226.
10. Felix, C.A. & Poplack, D.G. (1991) Characterization of acute lymphoblastic leukemia of childhood by immunoglobulin and T-cell receptor gene patterns. Leukemia, 5, 1015-1025.
11. Jaffe, E.S., Harris, N.L., Stein, H. & Vardiman, J.W., eds. (2001) World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. IARC, Lyon, France.
12. Larson, R.A., Dodge, R.K., Burns, C.P., Lee, E.J., Stone, R.M., Schulman, P., Duggan, D., Davey, F.R., Sobol, R.E., Frankel, S.R., Hooberman, A.L., Westbrook, C.A., Arthur, D.C., George, S.L., Bloomfield, C.D. & Schiffer, C.A. (1995) A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: cancer and Leukemia Group B Study 8811. Blood, 85, 2025-2037.
13. Ludwig, W.D., Bartram, C.R., Ritter, J., Raghavachar, A., Hiddemann, W., Heil, G., Harbott, J., Seibt-Jung, H., Teichmann, J.V. & Riehm, H. (1988) Ambiguous phenotypes and genotypes in 16 children with acute leukemia as characterized by multiparameter analysis. Blood, 71, 1518-1528.
14. Martin, P.L. (2000) Combination Chemotherapy in Treating Children With Acute Lymphoblastic Leukemia. In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). Available from NLM Identifier: NCT00005585.
15. Paietta, E., Neuberg, D., Richards, S., Bennett, J.M., Han, L., Racevskis, J., Dewald, G., Rowe, J.M. & Wiernik, P.H.; Eastern Cooperative Oncology Group (2001) Rare adult acute lymphocytic leukemia with CD56 expression in the ECOG experience shows unexpected phenotypic and genotypic heterogeneity. American Journal of Hematology, 66, 189-196.
16. Peterson, M.R., Noskoviak, K.J. & Newbury, R. (2007) CD5-positive B-cell acute lymphoblastic leukemia. Pediatric and Developmental Pathology, 10, 41-45.
17. Pieters, R. (2000) Comparison of Different Combination Chemotherapy Regimens in Treating Infants With Acute Lymphoblastic Leukemia. In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). Available from NLM Identifier: NCT00015873.
18. Pui, C.H., Pei, D., Sandlund, J.T., Ribeiro, R.C., Rubnitz, J.E., Raimondi, S.C., Onciu, M., Campana, D., Kun, L.E., Jeha, S., Cheng, C., Howard, S.C., Metzger, M.L., Bhojwani, D., Downing, J.R., Evans, W.E. & Relling, M.V. (2010) Long-term results of St Jude Total Therapy Studies 11, 12, 13A, 13B, and 14 for childhood acute lymphoblastic leukemia. Leukemia, 24, 371-382.
19. Rai, L., Casanova, A., Moorman, A.V., Richards, S., Buck, G., Goldstone, A.H., Fielding, A.K. & Foroni, L. (2010) Antigen receptor gene rearrangements reflect on the heterogeneity of adult Acute Lymphoblastic Leukaemia (ALL) with implications of cell-origin of ALL subgroups - a UKALLXII study. British Journal of Haematology, 148, 394-401.
20. Seegmiller, A.C., Kroft, S.H., Karandikar, N.J. & McKenna, R.W. (2009) Characterization of immunophenotypic aberrancies in 200 cases of B acute lymphoblastic leukemia. American Journal of Clinical Pathology, 132, 940-949.
21. Sevilla, D.W., Emmons, F.N., Colovai, A.I., Beaubier, N.T., Baker, C., Bhatia, M., Bhagat, G. & Alobeid, B. (2009) Hematogones are markedly reduced in pediatric acquired aplastic anemia: multiparametric flow cytometric analysis. Leukemia & Lymphoma, 50, 1951-1957.
22. Sevilla, D.W., Colovai, A.I., Emmons, F.N., Bhagat, G. & Alobeid, B. (2010) Hematogones: a review and update. Leukemia & Lymphoma, 51, 10-19.
23. Shaffer, L.G., Slovak, M.L. & Campbell, L.J., eds. (2009) ISCN (2009): International System of Human Cytogenetic Nomenclature. S Karger AG, Basel.
24. Silverman, L.B. (2000a) Treatment of Acute Lymphoblastic Leukemia in Children. In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). Available from NLM Identifier: NCT00165178.
25. Silverman, L.B. (2000b) Pegasparaginase or Asparaginase and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia. In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). Available from NLM Identifier: NCT00400946.
26. Stork, L.C., Matloub, Y., Broxson, E., La, M., Yanofsky, R., Sather, H., Hutchinson, R., Heerema, N.A., Sorrell, A.D., Masterson, M., Blever, A. & Gaynon, P.S. (2010) Oral 6-mercaptopurine versus oral 6-thioguanine and veno-occlusive disease in children with standard-risk acute lymphoblastic leukemia: report of the Children's Oncology Group CCG-1952 clinical trial. Blood, 115, 2740-2748.
27. Subirá, D., Roman, A., Jiménez-Garófano, C., Prieto, E., Martínez-Delgado, B., Aceituno, E., García, R. & Outeiriño, J. (1998) Brief report: CD19/CD5 acute lymphoblastic leukemia. Medical and Pediatric Oncology, 31, 551-552.
28. Swerdlow, S.H., Campo, E. & Harris, N.L., eds. (2008) World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues. IARC, Lyon, France.
29. Thomas, D.A., O'Brien, S., Cortes, J., Giles, F.J., Faderl, S., Verstovsek, S., Ferraioli, A., Koller, C., Beran, M., Pierce, S., Ha, C.S., Cabanillas, F., Keating, M.J. & Kantarjian, H. (2004) Outcome with the hyper-CVAD regimens in lymphoblastic lymphoma. Blood, 104, 1624-1630.
30. Uckun, F.M., Muraguchi, A., Ledbetter, J.A., Kishimoto, T., O'Brien, R.T., Roloff, J.S., Gajl-Peczalska, K., Provisor, A. & Koller, B. (1989) Biphenotypic leukemic lymphocyte precursors in CD2+ CD19+ acute lymphoblastic leukemia and their putative normal counterparts in human fetal hematopoietic tissues. Blood, 73, 1000-1015.
31. Vrooman, L.M., Neuberg, D.S., Stevenson, K.E., Supko, J.G., Sallan, S.E. & Silverman, L.B. (2009) Dexamethasone and individualized asparaginase dosing are each associated with superior event-free survival in childhood acute lymphoblastic leukemia: results from DFCI-ALL Consortium Protocol 00-01 [abstract]. Blood (ASH Annual Meeting Abstracts), 114, 321.
32. Winick, N.J. (2000) Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphocytic Leukemia. In: ClinicalTrials.gov [Internet]. Bethesda (MD): National Library of Medicine (US). Available from NLM Identifier: NCT00003671.